H
Hyperion DeFi, Inc. (HYPD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$2.47
-0.11 (-4.26%)
Market Cap: $39.84M
Last updated: Nov 17, 2026 at 11:05 AM ET
Hyperion DeFi, Inc. (HYPD) Valuation Multiples
Hyperion DeFi (HYPD) trades at 20.3x sales and 0.3x book value. Its P/B of 0.3x is below its 5-year median of 3.5x.
Current Multiples
Its enterprise value is 0.8x its EBITDA.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 20.3x |
| Price to book | 0.3x |
| EV/EBITDA | 0.8x |
| PEG | N/A |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 0.3x | 3.5x | N/A |
Valuation History
Over the 7 of the 8 year ends shown that have a P/B, its P/B ranged from 0.6x in 2025 to 24.5x in 2021. 2025 was the lowest of those years.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $3.56 | 26.6x | 0.6x |
| 2024 | $11.68 | 150.7x | N/A |
| 2023 | $166.40 | N/A | 5.3x |
| 2022 | $130.40 | N/A | 2.8x |
| 2021 | $320.00 | N/A | 24.5x |
| 2020 | $484.80 | N/A | 7.2x |
| 2019 | $358.40 | N/A | 4.4x |
| 2018 | $228.00 | N/A | 1.4x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About HYPD
Is HYPD stock overvalued?
GNG's valuation label for HYPD is Undervalued.
What is HYPD's price to sales ratio?
Hyperion DeFi has a price to sales ratio of 20.3x.
HYPD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors